Health Condition 1: null- Lower urinary tract symptoms Health Condition 2: N209- Urinary calculus, unspecified
Conditions
Interventions
Intervention1: Tamsulosin hydrochloride: Prescribed as Capsule 0.4 mgs at to be taken orally at bed time after meals once daily with sips of water for four weeks.
Control Intervention1: Lactobacillus:
Sponsors
University College of Medical Sciences University of Delhi and GTB Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1 All patients aged more than 18 to 80 years giving informed consent to participate in the study 2 Patients with urological disorders undergoing jj ureteral stenting
Exclusion criteria
Exclusion criteria: 1 Patient not willing for consent for inclusion in the above study 2 Symptomatic lower urinary tract symptoms LUTS due to BPH as diagnosed by history focused urological examination and investigations 3 Patients with pregnancy mental disorders or illness who cannot understand or comply with the study protocol 4 Patients with known history of orthostatic hypotension allergy hypersensitivity to one or more α adrenoceptor antagonists and or any component of the tamsulosin preparations 5 Patients receiving medications concomitantly in past 3 months with any alpha1 blocker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome were assessed by USSQ VAS IPSS urinary index score pain index score general health index score work performance score and sexual matters scoreTimepoint: Third day to fourth week post intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures were assessed by noting drug adverse events and side effects if any and overall drug tolerabilityTimepoint: Third day to fourth week post intervention | — |
Countries
India
Contacts
Public ContactDr Sambit Tripathy
University College of Medical Sciences University of Delhi and GTB Hospital
Outcome results
None listed